Catalyst Wire Dossier Catalyst Wire Dossier

MVA85A

Modified Vaccinia Ankara expressing antigen 85A · University of Oxford
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for MVA85A, covering 2007-01-18 to 2020-08-31. Get the full timeline:

Most recent: Clinical Trial Update: MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection [Phase 1]

See pricing